Want to join the conversation?
$AME 2Q15 Call: 2015 Outlook: Revenues to be up low-single digits on a percentage basis vs. 2014. Organic growth is expected to be roughly flat. Adjusted earnings of $2.58-2.63 per diluted share, up 7-9% over 2014. 3Q15 Outlook: Sales to be approx. flat versus 3Q14. Earnings to be approx. $0.64-0.65 per diluted share, up 3-5% over 3Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?